ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adoptive Cellular ImmunOthersapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-38R16861
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Adoptive Cellular ImmunOthersapy Market Research Report 2024
BUY CHAPTERS

Global Adoptive Cellular ImmunOthersapy Market Research Report 2025

Code: QYRE-Auto-38R16861
Report
September 2025
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARSGEN Therapeutics，Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc.
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Beijing Immunochina Medical Science & Technology Co Ltd

Adoptive Cellular ImmunOthersapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Adoptive Cellular ImmunOthersapy Market

Adoptive Cellular ImmunOthersapy Market

The global market for Adoptive Cellular ImmunOthersapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adoptive Cellular ImmunOthersapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cellular ImmunOthersapy.
The Adoptive Cellular ImmunOthersapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adoptive Cellular ImmunOthersapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adoptive Cellular ImmunOthersapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Adoptive Cellular ImmunOthersapy Market Report

Report Metric Details
Report Name Adoptive Cellular ImmunOthersapy Market
CAGR 5%
Segment by Type
  • TIL
  • LAK
  • CAR-T
  • TCR-T
  • CIK
  • NK
  • DC
  • Others
Segment by Application
  • Hospital
  • Cancer Hospital
  • Centers for Disease Control and Prevention
  • Rehabilitation Center
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp, Cell Medica Ltd, Cellular Biomedicine Group Inc, Celularity Inc, Celyad SA, Daiichi Sankyo Co Ltd, Fosun Pharmaceutical AG, Gilead Sciences Inc, Guangzhou Anjie Biomedical Technology Co Ltd, Hangzhou Converd Co Ltd, Hebei Senlang Biotechnology Inc Ltd, HRAIN Biotechnology Co Ltd, Juno Therapeutics Inc, Kite Pharma Inc, Nanjing Legend Biotech Co Ltd, NantKwest Inc, Nkarta Inc, Novartis AG, Ono Pharmaceutical Co Ltd, Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd, Sorrento Therapeutics Inc, Takara Bio Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Adoptive Cellular ImmunOthersapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adoptive Cellular ImmunOthersapy Market report?

Ans: The main players in the Adoptive Cellular ImmunOthersapy Market are Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp, Cell Medica Ltd, Cellular Biomedicine Group Inc, Celularity Inc, Celyad SA, Daiichi Sankyo Co Ltd, Fosun Pharmaceutical AG, Gilead Sciences Inc, Guangzhou Anjie Biomedical Technology Co Ltd, Hangzhou Converd Co Ltd, Hebei Senlang Biotechnology Inc Ltd, HRAIN Biotechnology Co Ltd, Juno Therapeutics Inc, Kite Pharma Inc, Nanjing Legend Biotech Co Ltd, NantKwest Inc, Nkarta Inc, Novartis AG, Ono Pharmaceutical Co Ltd, Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd, Sorrento Therapeutics Inc, Takara Bio Inc

What are the Application segmentation covered in the Adoptive Cellular ImmunOthersapy Market report?

Ans: The Applications covered in the Adoptive Cellular ImmunOthersapy Market report are Hospital, Cancer Hospital, Centers for Disease Control and Prevention, Rehabilitation Center, Others

What are the Type segmentation covered in the Adoptive Cellular ImmunOthersapy Market report?

Ans: The Types covered in the Adoptive Cellular ImmunOthersapy Market report are TIL, LAK, CAR-T, TCR-T, CIK, NK, DC, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 TIL
1.2.3 LAK
1.2.4 CAR-T
1.2.5 TCR-T
1.2.6 CIK
1.2.7 NK
1.2.8 DC
1.2.9 Others
1.3 Market by Application
1.3.1 Global Adoptive Cellular ImmunOthersapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cellular ImmunOthersapy Market Perspective (2020-2031)
2.2 Global Adoptive Cellular ImmunOthersapy Growth Trends by Region
2.2.1 Global Adoptive Cellular ImmunOthersapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adoptive Cellular ImmunOthersapy Historic Market Size by Region (2020-2025)
2.2.3 Adoptive Cellular ImmunOthersapy Forecasted Market Size by Region (2026-2031)
2.3 Adoptive Cellular ImmunOthersapy Market Dynamics
2.3.1 Adoptive Cellular ImmunOthersapy Industry Trends
2.3.2 Adoptive Cellular ImmunOthersapy Market Drivers
2.3.3 Adoptive Cellular ImmunOthersapy Market Challenges
2.3.4 Adoptive Cellular ImmunOthersapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cellular ImmunOthersapy Players by Revenue
3.1.1 Global Top Adoptive Cellular ImmunOthersapy Players by Revenue (2020-2025)
3.1.2 Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Players (2020-2025)
3.2 Global Adoptive Cellular ImmunOthersapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adoptive Cellular ImmunOthersapy Revenue
3.4 Global Adoptive Cellular ImmunOthersapy Market Concentration Ratio
3.4.1 Global Adoptive Cellular ImmunOthersapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cellular ImmunOthersapy Revenue in 2024
3.5 Global Key Players of Adoptive Cellular ImmunOthersapy Head office and Area Served
3.6 Global Key Players of Adoptive Cellular ImmunOthersapy, Product and Application
3.7 Global Key Players of Adoptive Cellular ImmunOthersapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cellular ImmunOthersapy Breakdown Data by Type
4.1 Global Adoptive Cellular ImmunOthersapy Historic Market Size by Type (2020-2025)
4.2 Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Type (2026-2031)
5 Adoptive Cellular ImmunOthersapy Breakdown Data by Application
5.1 Global Adoptive Cellular ImmunOthersapy Historic Market Size by Application (2020-2025)
5.2 Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adoptive Cellular ImmunOthersapy Market Size (2020-2031)
6.2 North America Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025)
6.4 North America Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adoptive Cellular ImmunOthersapy Market Size (2020-2031)
7.2 Europe Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025)
7.4 Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size (2020-2031)
8.2 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adoptive Cellular ImmunOthersapy Market Size (2020-2031)
9.2 Latin America Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025)
9.4 Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size (2020-2031)
10.2 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Adoptive Cellular ImmunOthersapy Introduction
11.1.4 Amgen Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.1.5 Amgen Inc Recent Development
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Details
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.2.5 Autolus Therapeutics Plc Recent Development
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Details
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.4.5 Bellicum Pharmaceuticals Inc Recent Development
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.5.5 Bristol-Myers Squibb Co Recent Development
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Details
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Adoptive Cellular ImmunOthersapy Introduction
11.6.4 bluebird bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.6.5 bluebird bio Inc Recent Development
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Details
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.7.5 CARsgen Therapeutics Ltd Recent Development
11.8 Celgene Corp
11.8.1 Celgene Corp Company Details
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Adoptive Cellular ImmunOthersapy Introduction
11.8.4 Celgene Corp Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.8.5 Celgene Corp Recent Development
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Details
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Adoptive Cellular ImmunOthersapy Introduction
11.9.4 Cell Medica Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.9.5 Cell Medica Ltd Recent Development
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Details
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.10.5 Cellular Biomedicine Group Inc Recent Development
11.11 Celularity Inc
11.11.1 Celularity Inc Company Details
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Adoptive Cellular ImmunOthersapy Introduction
11.11.4 Celularity Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.11.5 Celularity Inc Recent Development
11.12 Celyad SA
11.12.1 Celyad SA Company Details
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Adoptive Cellular ImmunOthersapy Introduction
11.12.4 Celyad SA Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.12.5 Celyad SA Recent Development
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Details
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.13.5 Daiichi Sankyo Co Ltd Recent Development
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Details
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.14.5 Fosun Pharmaceutical AG Recent Development
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Details
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.15.5 Gilead Sciences Inc Recent Development
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Details
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.17.5 Hangzhou Converd Co Ltd Recent Development
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Details
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.19.5 HRAIN Biotechnology Co Ltd Recent Development
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Details
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.20.5 Juno Therapeutics Inc Recent Development
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Details
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Adoptive Cellular ImmunOthersapy Introduction
11.21.4 Kite Pharma Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.21.5 Kite Pharma Inc Recent Development
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Details
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Development
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Details
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Adoptive Cellular ImmunOthersapy Introduction
11.23.4 NantKwest Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.23.5 NantKwest Inc Recent Development
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Details
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Adoptive Cellular ImmunOthersapy Introduction
11.24.4 Nkarta Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.24.5 Nkarta Inc Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Adoptive Cellular ImmunOthersapy Introduction
11.25.4 Novartis AG Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.25.5 Novartis AG Recent Development
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Details
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.26.5 Ono Pharmaceutical Co Ltd Recent Development
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Details
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.28.5 Sorrento Therapeutics Inc Recent Development
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Details
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Adoptive Cellular ImmunOthersapy Introduction
11.29.4 Takara Bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025)
11.29.5 Takara Bio Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARSGEN Therapeutics，Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc.
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Beijing Immunochina Medical Science & Technology Co Ltd
List of Tables
 Table 1. Global Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of TIL
 Table 3. Key Players of LAK
 Table 4. Key Players of CAR-T
 Table 5. Key Players of TCR-T
 Table 6. Key Players of CIK
 Table 7. Key Players of NK
 Table 8. Key Players of DC
 Table 9. Global Adoptive Cellular ImmunOthersapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Adoptive Cellular ImmunOthersapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Adoptive Cellular ImmunOthersapy Market Share by Region (2020-2025)
 Table 13. Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Adoptive Cellular ImmunOthersapy Market Share by Region (2026-2031)
 Table 15. Adoptive Cellular ImmunOthersapy Market Trends
 Table 16. Adoptive Cellular ImmunOthersapy Market Drivers
 Table 17. Adoptive Cellular ImmunOthersapy Market Challenges
 Table 18. Adoptive Cellular ImmunOthersapy Market Restraints
 Table 19. Global Adoptive Cellular ImmunOthersapy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Adoptive Cellular ImmunOthersapy Market Share by Players (2020-2025)
 Table 21. Global Top Adoptive Cellular ImmunOthersapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular ImmunOthersapy as of 2024)
 Table 22. Ranking of Global Top Adoptive Cellular ImmunOthersapy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Adoptive Cellular ImmunOthersapy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Adoptive Cellular ImmunOthersapy, Headquarters and Area Served
 Table 25. Global Key Players of Adoptive Cellular ImmunOthersapy, Product and Application
 Table 26. Global Key Players of Adoptive Cellular ImmunOthersapy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Adoptive Cellular ImmunOthersapy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Type (2020-2025)
 Table 30. Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Type (2026-2031)
 Table 32. Global Adoptive Cellular ImmunOthersapy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Application (2020-2025)
 Table 34. Global Adoptive Cellular ImmunOthersapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Application (2026-2031)
 Table 36. North America Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Amgen Inc Company Details
 Table 52. Amgen Inc Business Overview
 Table 53. Amgen Inc Adoptive Cellular ImmunOthersapy Product
 Table 54. Amgen Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 55. Amgen Inc Recent Development
 Table 56. Autolus Therapeutics Plc Company Details
 Table 57. Autolus Therapeutics Plc Business Overview
 Table 58. Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product
 Table 59. Autolus Therapeutics Plc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 60. Autolus Therapeutics Plc Recent Development
 Table 61. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
 Table 62. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
 Table 63. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 64. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 65. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
 Table 66. Bellicum Pharmaceuticals Inc Company Details
 Table 67. Bellicum Pharmaceuticals Inc Business Overview
 Table 68. Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product
 Table 69. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 70. Bellicum Pharmaceuticals Inc Recent Development
 Table 71. Bristol-Myers Squibb Co Company Details
 Table 72. Bristol-Myers Squibb Co Business Overview
 Table 73. Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product
 Table 74. Bristol-Myers Squibb Co Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 75. Bristol-Myers Squibb Co Recent Development
 Table 76. bluebird bio Inc Company Details
 Table 77. bluebird bio Inc Business Overview
 Table 78. bluebird bio Inc Adoptive Cellular ImmunOthersapy Product
 Table 79. bluebird bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 80. bluebird bio Inc Recent Development
 Table 81. CARsgen Therapeutics Ltd Company Details
 Table 82. CARsgen Therapeutics Ltd Business Overview
 Table 83. CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product
 Table 84. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 85. CARsgen Therapeutics Ltd Recent Development
 Table 86. Celgene Corp Company Details
 Table 87. Celgene Corp Business Overview
 Table 88. Celgene Corp Adoptive Cellular ImmunOthersapy Product
 Table 89. Celgene Corp Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 90. Celgene Corp Recent Development
 Table 91. Cell Medica Ltd Company Details
 Table 92. Cell Medica Ltd Business Overview
 Table 93. Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product
 Table 94. Cell Medica Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 95. Cell Medica Ltd Recent Development
 Table 96. Cellular Biomedicine Group Inc Company Details
 Table 97. Cellular Biomedicine Group Inc Business Overview
 Table 98. Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product
 Table 99. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 100. Cellular Biomedicine Group Inc Recent Development
 Table 101. Celularity Inc Company Details
 Table 102. Celularity Inc Business Overview
 Table 103. Celularity Inc Adoptive Cellular ImmunOthersapy Product
 Table 104. Celularity Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 105. Celularity Inc Recent Development
 Table 106. Celyad SA Company Details
 Table 107. Celyad SA Business Overview
 Table 108. Celyad SA Adoptive Cellular ImmunOthersapy Product
 Table 109. Celyad SA Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 110. Celyad SA Recent Development
 Table 111. Daiichi Sankyo Co Ltd Company Details
 Table 112. Daiichi Sankyo Co Ltd Business Overview
 Table 113. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 114. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 115. Daiichi Sankyo Co Ltd Recent Development
 Table 116. Fosun Pharmaceutical AG Company Details
 Table 117. Fosun Pharmaceutical AG Business Overview
 Table 118. Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product
 Table 119. Fosun Pharmaceutical AG Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 120. Fosun Pharmaceutical AG Recent Development
 Table 121. Gilead Sciences Inc Company Details
 Table 122. Gilead Sciences Inc Business Overview
 Table 123. Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product
 Table 124. Gilead Sciences Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 125. Gilead Sciences Inc Recent Development
 Table 126. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
 Table 127. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
 Table 128. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 129. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 130. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
 Table 131. Hangzhou Converd Co Ltd Company Details
 Table 132. Hangzhou Converd Co Ltd Business Overview
 Table 133. Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 134. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 135. Hangzhou Converd Co Ltd Recent Development
 Table 136. Hebei Senlang Biotechnology Inc Ltd Company Details
 Table 137. Hebei Senlang Biotechnology Inc Ltd Business Overview
 Table 138. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product
 Table 139. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 140. Hebei Senlang Biotechnology Inc Ltd Recent Development
 Table 141. HRAIN Biotechnology Co Ltd Company Details
 Table 142. HRAIN Biotechnology Co Ltd Business Overview
 Table 143. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 144. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 145. HRAIN Biotechnology Co Ltd Recent Development
 Table 146. Juno Therapeutics Inc Company Details
 Table 147. Juno Therapeutics Inc Business Overview
 Table 148. Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product
 Table 149. Juno Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 150. Juno Therapeutics Inc Recent Development
 Table 151. Kite Pharma Inc Company Details
 Table 152. Kite Pharma Inc Business Overview
 Table 153. Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product
 Table 154. Kite Pharma Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 155. Kite Pharma Inc Recent Development
 Table 156. Nanjing Legend Biotech Co Ltd Company Details
 Table 157. Nanjing Legend Biotech Co Ltd Business Overview
 Table 158. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 159. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 160. Nanjing Legend Biotech Co Ltd Recent Development
 Table 161. NantKwest Inc Company Details
 Table 162. NantKwest Inc Business Overview
 Table 163. NantKwest Inc Adoptive Cellular ImmunOthersapy Product
 Table 164. NantKwest Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 165. NantKwest Inc Recent Development
 Table 166. Nkarta Inc Company Details
 Table 167. Nkarta Inc Business Overview
 Table 168. Nkarta Inc Adoptive Cellular ImmunOthersapy Product
 Table 169. Nkarta Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 170. Nkarta Inc Recent Development
 Table 171. Novartis AG Company Details
 Table 172. Novartis AG Business Overview
 Table 173. Novartis AG Adoptive Cellular ImmunOthersapy Product
 Table 174. Novartis AG Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 175. Novartis AG Recent Development
 Table 176. Ono Pharmaceutical Co Ltd Company Details
 Table 177. Ono Pharmaceutical Co Ltd Business Overview
 Table 178. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 179. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 180. Ono Pharmaceutical Co Ltd Recent Development
 Table 181. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
 Table 182. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
 Table 183. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product
 Table 184. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 185. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
 Table 186. Sorrento Therapeutics Inc Company Details
 Table 187. Sorrento Therapeutics Inc Business Overview
 Table 188. Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product
 Table 189. Sorrento Therapeutics Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 190. Sorrento Therapeutics Inc Recent Development
 Table 191. Takara Bio Inc Company Details
 Table 192. Takara Bio Inc Business Overview
 Table 193. Takara Bio Inc Adoptive Cellular ImmunOthersapy Product
 Table 194. Takara Bio Inc Revenue in Adoptive Cellular ImmunOthersapy Business (2020-2025) & (US$ Million)
 Table 195. Takara Bio Inc Recent Development
 Table 196. Research Programs/Design for This Report
 Table 197. Key Data Information from Secondary Sources
 Table 198. Key Data Information from Primary Sources
 Table 199. Authors List of This Report


List of Figures
 Figure 1. Adoptive Cellular ImmunOthersapy Picture
 Figure 2. Global Adoptive Cellular ImmunOthersapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Adoptive Cellular ImmunOthersapy Market Share by Type: 2024 VS 2031
 Figure 4. TIL Features
 Figure 5. LAK Features
 Figure 6. CAR-T Features
 Figure 7. TCR-T Features
 Figure 8. CIK Features
 Figure 9. NK Features
 Figure 10. DC Features
 Figure 11. Others Features
 Figure 12. Global Adoptive Cellular ImmunOthersapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Adoptive Cellular ImmunOthersapy Market Share by Application: 2024 VS 2031
 Figure 14. Hospital Case Studies
 Figure 15. Cancer Hospital Case Studies
 Figure 16. Centers for Disease Control and Prevention Case Studies
 Figure 17. Rehabilitation Center Case Studies
 Figure 18. Others Case Studies
 Figure 19. Adoptive Cellular ImmunOthersapy Report Years Considered
 Figure 20. Global Adoptive Cellular ImmunOthersapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global Adoptive Cellular ImmunOthersapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global Adoptive Cellular ImmunOthersapy Market Share by Region: 2024 VS 2031
 Figure 23. Global Adoptive Cellular ImmunOthersapy Market Share by Players in 2024
 Figure 24. Global Top Adoptive Cellular ImmunOthersapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular ImmunOthersapy as of 2024)
 Figure 25. The Top 10 and 5 Players Market Share by Adoptive Cellular ImmunOthersapy Revenue in 2024
 Figure 26. North America Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America Adoptive Cellular ImmunOthersapy Market Share by Country (2020-2031)
 Figure 28. United States Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Adoptive Cellular ImmunOthersapy Market Share by Country (2020-2031)
 Figure 32. Germany Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Nordic Countries Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Adoptive Cellular ImmunOthersapy Market Share by Region (2020-2031)
 Figure 40. China Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Adoptive Cellular ImmunOthersapy Market Share by Country (2020-2031)
 Figure 48. Mexico Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Adoptive Cellular ImmunOthersapy Market Share by Country (2020-2031)
 Figure 52. Turkey Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE Adoptive Cellular ImmunOthersapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Amgen Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 56. Autolus Therapeutics Plc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 57. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 58. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 59. Bristol-Myers Squibb Co Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 60. bluebird bio Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 61. CARsgen Therapeutics Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 62. Celgene Corp Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 63. Cell Medica Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 64. Cellular Biomedicine Group Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 65. Celularity Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 66. Celyad SA Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 67. Daiichi Sankyo Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 68. Fosun Pharmaceutical AG Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 69. Gilead Sciences Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 70. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 71. Hangzhou Converd Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 72. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 73. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 74. Juno Therapeutics Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 75. Kite Pharma Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 76. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 77. NantKwest Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 78. Nkarta Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 79. Novartis AG Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 80. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 81. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 82. Sorrento Therapeutics Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 83. Takara Bio Inc Revenue Growth Rate in Adoptive Cellular ImmunOthersapy Business (2020-2025)
 Figure 84. Bottom-up and Top-down Approaches for This Report
 Figure 85. Data Triangulation
 Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Adoptive Cell Transfer Therapy Market Research Report 2024
Global Adoptive Cell Therapy Market Insights Forecast to 2030
Global Cell Based Immunotherapy Market Research Report 2024
Global T Cell Immunotherapy Market Research Report 2025
Global Novel T Cell Immunotherapies Market Research Report 2024
Global CAR T Cellular Immunotherapy Drug Market Research Report 2024
Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2024
Global Cellular Allografts Market Research Report 2024
Global Cell based Flow Cytometry Market Research Report 2025
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024
Global T Cell Transfer Therapy Market Research Report 2024
Global Immuno Cell Therapy Market Research Report 2024
Global Cell Immunotherapy Platform Market Research Report 2024
Global Allergy Immunotherapies Market Research Report 2025
Global Immunocell Therapy Market Insights Forecast to 2030
Global Cell Therapy Manufacturing Market Research Report 2025
Global Cell Transplantatio Therapy Market Insights Forecast to 2030
Global Immunological Agents Market Research Report 2024
CAR T Cell Immunotherapies for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric CAR T cell Therapy Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions